Take Solutions Ltd
NSE:TAKE
Take Solutions Ltd
NSE:TAKE
Price:
21.25 INR
-4.06%
Market Closed
Updated:
May 8, 2024
Section:
Relative Value
The Relative Value of one
TAKE
stock under the Base Case scenario is
9.11
INR.
Compared to the current market price of 21.25 INR,
Take Solutions Ltd
is
Overvalued by 57%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TAKE
Relative Value
Base Case
9.11
INR
Overvaluation 57%
Valuation Multiples
Multiples Across Competitors
TAKE Competitors Multiples
Take Solutions Ltd Competitors
Take Solutions Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Take Solutions Ltd
NSE:TAKE
|
3.1B INR | 3.7 | -4.8 | 17 | 40.3 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
33.1B USD | 14 | 63 | 62.5 | 67.2 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.8B AUD | 80.8 | 169.5 | 116.5 | 116.5 | |
| JP |
|
M3 Inc
TSE:2413
|
1.2T JPY | 4.9 | 24.9 | 13 | 14.6 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.3B USD | 11.6 | -343.3 | -185.9 | -172.8 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.7 | 33 | 22.1 | 23.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
43B SEK | 26.3 | 101.3 | -66.7 | -66.7 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -22.1 | 25.7 | 274 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
3B USD | 4 | -334.6 | 36.2 | -118.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
